Daily FNArena News - Australia

Life science stocks are not exactly investor favourites at present but ABN Amro Morgans sees Acrux as a standout in the sector given its technology and solid financial position.

The RBA has clearly become more concerned about inflation, but still anticipates a fall ahead.

As expected, the RBA has left its cash rate unchanged at 7.25%.

All of a sudden, the mobile phone is emerging as the most important medium for the future of advertising.

Babcock & Brown received some good news yesterday when its banking syndicate waived the need to review the facility but with asset sales still needed brokers are not getting too excited.

Austock Securities has toured the assets of Macquarie Infrastructure Fund and this has not changed the stockbroker’s positive view on the stock at current levels.

The TD Securities-Melbourne Institute Inflation Gauge shows higher fuel and rent prices are keeping the pressure on inflation, meaning interest rates may yet go higher.

Malachite Resources believes it is sitting on a long term silver mine of globally comparable significance.

It is taking some time to achieve, but Westpac believes the RBA’s tightening policy will achieve the desired slowdown.

Wotif’s updated guidance has come in below consensus forecasts, but it’s not the end of the world.